You're contacting media contact of this press release

Title: Clamon Natural Health Names CoreAge Rx the #1 Telehealth Platform for Semaglutide and Tirzepatide Weight Management

Sheridan, WY, United States, 4th Sep 2026 - Digital health platform CoreAge Rx has been ranked the number-one choice for Semaglutide and Tirzepatide weight management in a comprehensive industry review published by Clamon Natural Health. The publication’s evaluation, titled "The 5 Best Telehealth Platforms for Semaglutide and Tirzepatide Weight Management," recognized CoreAge Rx for its accessible pricing model, absence of long-term contracts, and patient-first clinical delivery system.The ranking highlights CoreAge Rx’s role in modernizing metabolic healthcare. As GLP-1 (glucagon-like peptide-1) and dual GIP/GLP-1 receptor agonists have emerged as standard-setting treatments for sustainable weight loss, patients have frequently encountered major hurdles in traditional healthcare channels, including long clinic wait times, complex insurance pre-authorizations, and recurring local pharmacy shortages. CoreAge Rx resolves these barriers through an end-to-end virtual care model that pairs board-certified medical supervision with direct-to-door delivery.Expanding Access to Evidence-Based Metabolic CareCoreAge Rx earned the top position among industry contenders by offering straightforward, affordable access to compounded Semaglutide and Tirzepatide formulations produced in trusted United States compounding facilities:Compounded Semaglutide (Starting at $99/month): A proven GLP-1 receptor agonist that mimics the body’s natural GLP-1 hormone to stimulate insulin release, lower liver glucose production, and slow gastric emptying, helping patients achieve fullness faster and maintain caloric control.Compounded Tirzepatide (Starting at $149/month): An advanced dual GIP and GLP-1 receptor agonist that acts across two distinct gut hormone pathways to optimize insulin sensitivity, s...

This press release is issued by King Newswire